Brind.

Kyverna Therapeutics announced its trial design is FDA-aligned and hosted a virtual KOL event.

Steady: 0 in the last 7 days Updated nov 12

The latest in this situation

  1. Kyverna filed BLA with FDA.

How it started

2 reports, 2 independent, last reported Nov 12. The briefing below covers this first event.

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Kyverna Therapeutics announced its trial design is FDA-aligned and hosted a virtual KOL event.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Kyverna filed BLA with FDA.1 source
  2. Kyverna hosts events featuring Srikanth Muppidi and Aiden Haghikia, who is affiliated with Hannover Medical School.Sub-event
  3. Kyverna's trial design received FDA alignment, accompanied by a virtual KOL event.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • manilatimes.net
  • GlobeNewswireKyverna Therapeutics Highlights Neuroimmunology CAR T Franchise and Registrational Phase 3 Trial Design in Myasthenia Gravis at Virtual KOL Event KYV-101 has the potential to deliver durable, drug-fr